Foxo1 and the insulin resistance of cultured kidney cells

October 31, 2001

As a normal aspect of energy metabolism, cells in the kidney, much like those in the liver, respond to insulin by suppressing the metabolic pathways by which glucose is generated and released. In the healthy kidney, expression of the enzyme glucose 6-phosphatase (G6P), which controls a key step in glycogen breakdown, is suppressed by insulin. Curiously, this and other aspects of the transcriptional control by insulin are lacking in cultured kidney cells. In hopes of uncovering a general mechanism by which insulin sensitivity could be gained or lost, Nakae et al. have now studied insulin responses in kidney epithelial cell lines. They show here that the transcription factor Foxo1, which is present in the normal tissue but only weakly expressed in the cell line, is sufficient to restore insulin regulation of transcripts that are sensitive to glucose levels. Previous work had suggested that Foxo1 binding to the G6P promoter accounts for activation of gene expression by glucose and the corresponding silencing of expression following insulin treatment. The present work shows that he transcription factor becomes phosphorylated and is excluded from the nucleus following insulin treatment, which may explain at least some of the suppressive effect of this hormone on G6P and related genes. Whether reduced expression or increased phosphorylation of Foxo1 contribute to the loss of insulin sensitivity seen in the kidney or other organs in vivo remains to be tested.
-end-


JCI Journals

Related Insulin Articles from Brightsurf:

US Insulin prices 8 times higher than in other nations
Insulin list prices in the United States have increased dramatically over the past decade, with per person insulin spending doubling between 2012 and 2016.

A gatekeeper against insulin resistance in the brain
The brain plays a major role in controlling our blood glucose levels.

Sorting and secreting insulin by expiration date
Visualizing the age of insulin secreting granules in cells allowed researchers to investigate how cells' preference for secreting newer granules is disrupted in diabetes.

Researchers develop a new ultrafast insulin
Stanford researchers tested a new insulin drug in diabetic pigs and found that it was twice as fast-acting as traditional insulin.

Insulin signaling suppressed by decoys
The discovery of an insulin 'decoy' molecule from the lab of Matthew Gill, PhD, in Florida shakes up understanding of insulin signaling, with implications for diabetes, longevity and aging research.

New mechanism for dysfunctional insulin release identified
In a new study, researchers at Uppsala University have identified a previously unknown mechanism that regulates release of insulin, a hormone that lowers blood glucose levels, from the β-cells (beta cells) of the pancreas.

Type 2 diabetes is not just about insulin
Obesity, by promoting the resistance to the action of insulin, is a major risk factor of diabetes.

The insulin under the influence of light
By understanding how the brain links the effects of insulin to light, researchers (UNIGE) are deciphering how insulin sensitivity fluctuates according to circadian cycles.

Does insulin resistance cause fibromyalgia?
Researchers led by a team from The University of Texas Medical Branch at Galveston were able to dramatically reduce the pain of fibromyalgia patients with medication that targeted insulin resistance.

Insulin insights
Insulin triggers genome-wide changes in gene expression via an unexpected mechanism.

Read More: Insulin News and Insulin Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.